Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia
Pulses of Vincristine and Dexamethasone During Maintenance in BFM Protocols for Children With Intermediate-Risk Acute Lymphoblastic Leukemia
Sponsor: Associazione Italiana Ematologia Oncologia Pediatrica
A PHASE4 clinical study on Acute Lymphoblastic Leukemia, this trial is completed. The trial is conducted by Associazione Italiana Ematologia Oncologia Pediatrica and has accumulated 7 data snapshots since 1995. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Apr 2019 — Sep 2019 [monthly]
Completed PHASE4
-
Jan 2017 — Apr 2019 [monthly]
Completed PHASE4
First recorded
Apr 1995
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Associazione Italiana Ematologia Oncologia Pediatrica
- BFM-A, Austria
- BFM-G, Germany and Switzerland
- CPH, Czech republic
- European Organisation for Research and Treatment of Cancer - EORTC
- Group for Acute Leukemia Treatment (GATLA).
- H-POG (Hungary Pediatric Oncology Group)
- International BFM Study Group
- PINDA, Chile
For direct contact, visit the study record on ClinicalTrials.gov .